Authors
Loading...
Chronic inflammation reduces hematopoiesis in hematopoietic stem cells, indicating MAVS may be a therapeutic target in myelodysplastic syndromes.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: